Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00270569 | An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer | unknown | Phase 2 | 43 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00309920 | Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | unknown | N/A | 1,234 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00299117 | Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery | completed | N/A | 130 | Herlev HospitalOTHER | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00276211 | Diffusion Weighted MRI for Lymphnodes in the Axilla | completed | — | 10 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00174434 | Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer | completed | Phase 1 | 22 | PfizerINDUSTRY | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00612443 | Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy | completed | Phase 2 / Phase 3 | 40 | University of Wisconsin, MilwaukeeOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00353717 | Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma | unknown | Phase 1 / Phase 2 | 25 | Hadassah Medical OrganizationOTHER | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00809484 | Arimidex Bone Mass Index and Oral Bisphosphonates(ARBI) | completed | — | 220 | Hellenic Breast Surgeons SocietyOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | completed | — | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00815555 | CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients | unknown | — | 500 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Dec 30, 2008 | clinicaltrials |
| NCT00810706 | Adjuvant Post-Tamoxifen Exemestane Trial(ATENA) | terminated | Phase 3 | 448 | Hellenic Breast Surgeons SocietyOTHER | 1 | Dec 18, 2008 | clinicaltrials |
| NCT00808522 | Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women | unknown | Phase 3 | 84 | New York Presbyterian HospitalOTHER | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00583739 | Yoga to Reduce Cancer Fatigue | completed | Phase 2 | 66 | University of IowaOTHER | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00078000 | A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. | completed | Phase 2 | 64 | PfizerINDUSTRY | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 76 | NSABP Foundation IncNETWORK | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00188591 | Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00198250 | Venlafaxine for Hot Flashes After Breast Cancer | completed | Phase 2 | 75 | Indiana UniversityOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00403988 | Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma | terminated | Phase 2 | 40 | American University of Beirut Medical CenterOTHER | 1 | Nov 4, 2008 | clinicaltrials |
| NCT00237354 | PV-10 Chemoablation of Recurrent Breast Carcinoma | completed | Phase 1 | 15 | Provectus PharmaceuticalsINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00777530 | Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects | completed | Phase 1 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Oct 23, 2008 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00303615 | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer | terminated | Phase 2 | 5 | Legacy Health SystemOTHER | 1 | Oct 20, 2008 | clinicaltrials |
| NCT00072852 | Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine | completed | Phase 2 | 134 | PfizerINDUSTRY | 5 | Oct 16, 2008 | clinicaltrials |
| NCT00027131 | Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 | terminated | Phase 1 / Phase 2 | 15 | UConn HealthOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00156260 | Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage | terminated | — | 88 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00228930 | Tamoxifen Pharmacogenetics and Clinical Effects | completed | — | 297 | National Institute of General Medical Sciences (NIGMS)NIH | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00228956 | Aromatase Inhibitor Clinical Trial | unknown | — | 500 | National Institute of General Medical Sciences (NIGMS)NIH | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00380835 | Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer | withdrawn | Phase 2 | 66 | Celgene CorporationINDUSTRY | 1 | Sep 23, 2008 | clinicaltrials |
| NCT00328432 | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | completed | Phase 1 | 100 | University of KansasOTHER | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00291109 | An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg | completed | — | 40 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00291122 | An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | completed | — | 100 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00594282 | Use of a Radiolucent Pad to Reduce Mammography Among African Americans | completed | N/A | 300 | University of KansasOTHER | 1 | Sep 12, 2008 | clinicaltrials |
| NCT00187343 | A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | completed | Phase 3 | 340 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 8, 2008 | clinicaltrials |
| NCT00120029 | Peer Counseling for Weight Loss | unknown | N/A | 100 | Wayne State UniversityOTHER | 1 | Sep 5, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00558168 | Electronic Study for Anastrozole Pharmacovigilance Evaluation(E-SAFE) | completed | — | 1,850 | AstraZenecaINDUSTRY | 0 | Jul 28, 2008 | clinicaltrials |
| NCT00717951 | A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer | unknown | Phase 2 | 120 | Academy Military Medical Science, ChinaINDUSTRY | 0 | Jul 25, 2008 | clinicaltrials |
| NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00025688 | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer | unknown | Phase 3 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00162812 | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin(TOP) | terminated | Phase 2 | 338 | Jules Bordet InstituteOTHER | 1 | Jul 18, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
Data updated 24 days agoSource updated Feb 9, 2009source: clinicaltrials